DeepSeek for doctors: Wang Xiaochuan makes medical AI free

Wang Xiaochuan, a well-known figure in China's tech world, has made a bold move: his company DeepSeek has released a free version of its artificial intelligence platform for doctors. The stated goal is to give healthcare workers a powerful tool that can improve the efficiency of diagnosis and treatment. According to the developers, the key advantage is an extremely low "hallucination" rate: below 3%.

DeepSeek is a Chinese startup that develops large language models (LLMs) and applies AI across various industries. Healthcare is one of its priority areas. The decision to release a free version is probably driven by a desire to capture market share quickly and gather feedback from users. In the fiercely competitive Chinese AI market, such a move could prove decisive.

The hallucination (error) rate of large language models is critically important, especially in healthcare. Even a small probability of error can lead to wrong diagnoses and, as a result, serious consequences for patients. DeepSeek's claim of less than 3% hallucinations is a serious bid for leadership in this field. However, the methods for measuring and defining "hallucinations" can differ, and the system's real-world effectiveness will depend on many factors, including the quality of the data it was trained on and the specifics of clinical tasks.

Free access to a medical AI platform could significantly speed up the adoption of artificial intelligence in China's healthcare system. Many doctors, especially in small cities and rural areas, lack access to modern diagnostic tools and expert knowledge. AI could become a reliable assistant for them, helping raise the quality of care and reduce the likelihood of errors. However, medical staff need training, and clear protocols for using AI must be established, to avoid excessive reliance on the technology and preserve critical thinking.

Introducing AI into medicine is a complex, multifaceted process that requires not only technological innovation but also answers to ethical and legal questions. Patients' personal data must be protected, discrimination prevented, and responsibility for decisions guaranteed. Despite DeepSeek's optimistic claims, medical AI should be used with caution, and the human factor must not be forgotten.

DeepSeek's decision to make its medical AI platform free is an interesting precedent that could reshape the medical AI market in China. It also raises important questions about the accessibility, safety and ethics of using artificial intelligence in healthcare. Ultimately, the success of the effort will depend on how effectively DeepSeek can address these questions and win the trust of the medical community.